Can frontotemporal (FTD) Alzheimer's disease cause auditory hallucinations?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 12, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Auditory Hallucinations in Frontotemporal Dementia and Alzheimer's Disease

Yes, frontotemporal dementia (FTD) can cause auditory hallucinations, particularly in patients with the C9orf72 genetic mutation, where auditory hallucinations are reported in 21-56% of cases. 1

Types of Dementia and Hallucination Patterns

Frontotemporal Dementia (FTD)

  • Genetic FTD variants:

    • C9orf72 mutation carriers: Most strongly associated with auditory hallucinations
      • Auditory hallucinations reported in 21-56% of cases 1
      • Often precede classical FTD symptoms by up to a decade 1
      • Mostly manifest as human voices 1
    • GRN mutations: Visual hallucinations and delusions occur in up to 25% of patients 1
    • MAPT mutations: Paranoid delusions and hallucinations reported in some cases, but less common 1
  • Clinical presentation of hallucinations in FTD:

    • Often occur alongside other behavioral symptoms
    • May be an early indicator of C9orf72 genetic variant 1
    • Can present as part of a psychiatric syndrome before other cognitive symptoms emerge

Dementia with Lewy Bodies (DLB)

  • Recurrent visual hallucinations are a core diagnostic criterion 1
  • Auditory hallucinations occur in 35.5% of DLB patients 2
  • 90.9% of DLB patients with auditory hallucinations also have visual hallucinations 2
  • Auditory hallucinations in DLB typically manifest as "soundtracks" accompanying visual hallucinations 2

Alzheimer's Disease (AD)

  • Auditory hallucinations occur in approximately 10% of AD patients 3
  • Visual hallucinations are more common (13%) 3
  • Hallucinations in AD are associated with:
    • More rapid cognitive decline 3
    • Lower quality of life and wellbeing 4
    • Poor inhibitory control 5

Diagnostic Considerations

When evaluating a patient with suspected FTD and auditory hallucinations:

  1. Consider genetic testing:

    • C9orf72 screening is recommended for all cases of possible or probable behavioral variant FTD (bvFTD), regardless of family history 1
    • C9orf72 screening should be strongly considered in cases with prominent psychiatric symptoms 1
  2. Evaluate for other neuropsychiatric symptoms:

    • Delusions (persecutory, jealousy, grandiosity, religiosity, somatic) 1
    • Depression (may mediate the relationship between inhibitory control and hallucinations) 5
    • Executive dysfunction, particularly inhibitory control deficits 5
  3. Differential diagnosis:

    • Consider DLB if hallucinations are predominantly visual and accompanied by parkinsonism, REM sleep behavior disorder, and fluctuating cognition 1
    • Consider AD if memory impairment is the predominant feature 1
    • Consider psychiatric disorders, especially in younger patients or those with C9orf72 mutations 1

Clinical Implications

  • Presence of auditory hallucinations in dementia is associated with:

    • Lower quality of life and wellbeing 4
    • More rapid cognitive decline 3
    • Greater caregiver burden
  • Diagnostic value:

    • Auditory hallucinations in the context of behavioral changes may suggest FTD, particularly with C9orf72 mutation 1
    • When combined with visual hallucinations and parkinsonism, suggests DLB 1
    • In AD, hallucinations predict more rapid deterioration 3

Pitfalls and Caveats

  1. Misdiagnosis risk: FTD with prominent psychiatric symptoms (including auditory hallucinations) is often misdiagnosed as a primary psychiatric disorder, particularly in early stages 1

  2. Genetic implications: C9orf72 mutations can present with psychiatric symptoms years before classical FTD symptoms emerge 1

  3. Assessment challenges: Patients may not spontaneously report hallucinations, making caregiver reports crucial

  4. Treatment considerations: Antipsychotics should be used cautiously due to increased risk of adverse effects, particularly in DLB 1

In summary, auditory hallucinations can occur in frontotemporal dementia, particularly in patients with the C9orf72 genetic mutation. They may precede other cognitive symptoms and should prompt consideration of genetic testing, especially when accompanied by other psychiatric symptoms or a family history of neuropsychiatric disorders.

References

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.